Our focus

We support the pharmaceutical, medtech, and biotechnology industries in all legal, regulatory, and legal policy matters:
  • Medicines, personalized medicine, medical devices, novel foods, dietary supplements, foods for special medical purposes, cannabis, doping agents, cosmetics
  • Artificial intelligence as a medical device, other high-risk AI applications, access to data and training data sets
  • Drug development, collaborations, and licenses
  • Market access, price regulation & regulatory affairs, advanced therapies & early access
  • Organizational law, quality assurance law (GMP, GDP), and innovation, start-up, and technology law
  • Compliance & competition law
We support hospitals, medical practices, pharmacies, medical care centers, associations, and non-profit organizations in key issues of modern healthcare:
  • Cooperation. Mergers and restructuring of hospitals
  • Outpatient care in hospitals
  • Practice contracts, MVZ start-ups, and approvals
  • Fee assessment reviews, representation against the Medical Service, representation against medical malpractice lawsuits
  • Representation of pharmacies in pharmacy sales, in matters relating to prescription drugs, as well as platform issues and other distribution issues
We provide comprehensive advice to healthcare stakeholders on all issues relating to digital transformation, digital innovation, and the digital future in healthcare law. Our focus is on:
  • AI Act, European Health Data Space, Health Data Use Act, Data Governance Act, Data Act
  • Tailored training for owners, board members, supervisory board members, and employees in companies on AI competence, digital competence, and human oversight
  • Telematics infrastructure, electronic patient records (ePA), and electronic prescriptions
  • Telemedicine and video consultations
  • Digital health applications (DiGA) and digital care applications (DiPA)
  • Interoperability and IT compliance, data access, data protection and data security, cyber security

Scroll to Top